Given the clinical relevance of HER2 amplification and PD-L1 expression in GC, we conducted a retrospective analysis of genetic testing data to evaluate the concordance between next-generation sequencing (NGS) and fluorescence in situ hybridization (FISH), the gold standard for HER2 amplification detection. Here, ERBB2 is linked to gastric cancer.